Important information regarding cookies and
By using this website, you consent to the use of cookies in accordance with the IMB Cookie Policy. For more information on cookies, see our Cookie Policy.
Full Version | Search

The Irish Medicines Board -

IMB Logo

IMB Newsletter Issue No. 36 May - August 2010

17 September 2010

Download: IMB Newsletter Issue No. 36 May - August 2010


  • Signing of Memorandum of Understanding between The Therapeutic Goods Administration of Australia and the IMB
  • Herbal medicines on the Irish market 2010
  • Authorisation or registration numbering system

Human Medicines

  • Project to update the legal status of centrally authorised medicinal products
  • Change in the procedure for requesting Ireland to act as Reference Member State (RMS) in a decentralised procedure for a human medicinal product

Veterinary Medicines

  • Collection of data on veterinary consumption of antimicrobials
  • Update on status of flukicides without MRL for milk
  • Staff changes


  • Requirements for QP declarations for inclusion of third-country contract manufacturers/testing facilities for IMP authorisation
  • Meeting of the PIC/S Expert Circle on active substances
  • Persistent Organic Pollutants Regulations 2010, S.I. No. 235 of 2010 ('POPs Regulations')
  • Reporting of quality defects
  • Micronisation of active substances
  • Controlled drugs - update to Misuse of Drugs Regulations 2010
  • Use of small volume cold chain insulated shippers
  • Cosmetics update
  • Joint inspections with the US FDA (notice reprinted from EMA website)
  • GMP and market compliance information day


Date Printed: 16 April 2014

© Irish Medicines Board 2014 | Developed by Engine Solutions

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971